相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Angiotensin II receptor blockers valsartan and losartan improve survival rate clinically and suppress tumor growth via apoptosis related to PI3K/AKT signaling in nasopharyngeal carcinoma
Yu-Tsai Lin et al.
CANCER (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Anti-Hypertensive Medication Combinations in the United States
Michael E. Johansen et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2020)
Statin use associated with improved overall and cancer specific survival in patients with head and neck cancer
Abhinav Gupta et al.
ORAL ONCOLOGY (2019)
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer A Phase 2 Clinical Trial
Janet E. Murphy et al.
JAMA ONCOLOGY (2019)
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial
Anthony C. Nichols et al.
LANCET ONCOLOGY (2019)
Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset
William A. Stokes et al.
ORAL ONCOLOGY (2018)
The characteristics and risk factors for cisplatin-induced acute kidney injury in the elderly
Jie-qiong Liu et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2018)
Angiotensin 1-7 inhibits angiotensin II-stimulated head and neck cancer progression
E. E. Hinsley et al.
EUROPEAN JOURNAL OF ORAL SCIENCES (2017)
Postdiagnostic use of β-blockers and other antihypertensive drugs and the risk of recurrence and mortality in head and neck cancer patients: an observational study of 10,414 person-years of follow-up
S. -A. Kim et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2017)
Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study
Sadayuki Kawai et al.
BMC CANCER (2017)
Angiotensin-converting enzyme inhibitors predict acute kidney injury during chemoradiation for head and neck cancer
Michael T. Spiotto et al.
ANTI-CANCER DRUGS (2015)
Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522
K. Kian Ang et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Angiotensin II Induces Angiogenic Factors Production Partly Via AT1/JAK2/STAT3/SOCS3 Signaling Pathway in MHCC97H Cells
Yuanyuan Ji et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2012)
Mechanisms and Treatment of CKD
Piero Ruggenenti et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Statin Use and Reduced Cancer-Related Mortality
Sune F. Nielsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis
Nicolas Clere et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth
M Fujita et al.
CARCINOGENESIS (2005)
Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells
R Yasumatsu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Chymase is upregulated in diabetic nephropathy: Implications for an alternative pathway of angiotensin II - Mediated diabetic renal and vascular disease
XR Huang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Development of a comorbidity index using physician claims data
CN Klabunde et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)
Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine - Is this a cause for concern?
GL Bakris et al.
ARCHIVES OF INTERNAL MEDICINE (2000)